000 | 01428 a2200421 4500 | ||
---|---|---|---|
005 | 20250515080337.0 | ||
264 | 0 | _c20071025 | |
008 | 200710s 0 0 eng d | ||
022 | _a0176-3679 | ||
024 | 7 |
_a10.1055/s-2007-984399 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMolina, V | |
245 | 0 | 0 |
_aMarked hypofrontality in clozapine-responsive patients. _h[electronic resource] |
260 |
_bPharmacopsychiatry _cJul 2007 |
||
300 |
_a157-62 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
650 | 0 | 4 |
_aCaudate Nucleus _xdrug effects |
650 | 0 | 4 |
_aClozapine _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorodeoxyglucose F18 _xpharmacokinetics |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aFrontal Lobe _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPositron-Emission Tomography |
650 | 0 | 4 |
_aPrefrontal Cortex _xdrug effects |
650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
650 | 0 | 4 |
_aSchizophrenia _xdiagnostic imaging |
650 | 0 | 4 |
_aThalamus _xdrug effects |
700 | 1 | _aSanz, J | |
700 | 1 | _aSarramea, F | |
700 | 1 | _aPalomo, T | |
773 | 0 |
_tPharmacopsychiatry _gvol. 40 _gno. 4 _gp. 157-62 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2007-984399 _zAvailable from publisher's website |
999 |
_c17226079 _d17226079 |